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Abstract 
Objective:  To validate a brief measure of vaccination confidence using a large, nationally 
representative sample of parents. 
Methods:  We analyzed weighted data from 9018 parents who completed the 2010 National 
Immunization Survey–Teen, an annual, population-based telephone survey. Parents 
reported on the immunization history of a 13- to 17-year-old child in their households for 
vaccines including tetanus, diphtheria, and acellular pertussis (Tdap), meningococcal, and 
human papillomavirus vaccines. For each vaccine, separate logistic regression models 
assessed associations between parents' mean scores on the 8-item Vaccination Confidence 
Scale and vaccine refusal, vaccine delay, and vaccination status. We repeated analyses for 
the scale's 4-item short form. 
Results:  One quarter of parents (24%) reported refusal of any vaccine, with refusal of 
specific vaccines ranging from 21% for human papillomavirus to 2% for Tdap. Using the full 
8-item scale, vaccination confidence was negatively associated with measures of vaccine 
refusal and positively associated with measures of vaccination status. For example, refusal 
of any vaccine was more common among parents whose scale scores were medium (odds 
ratio, 2.08; 95% confidence interval, 1.75–2.47) or low (odds ratio, 4.61; 95% confidence 
interval, 3.51–6.05) versus high. For the 4-item short form, scores were also consistently 
associated with vaccine refusal and vaccination status. Vaccination confidence was 
inconsistently associated with vaccine delay. 
Conclusions:  The Vaccination Confidence Scale shows promise as a tool for identifying 
parents at risk for refusing adolescent vaccines. The scale's short form appears to offer 
comparable performance. 
Keywords:  adolescent health, human papillomavirus vaccine, immunization, 
meningococcal vaccine, tetanus vaccine, vaccine hesitancy 
What's New 
Using data from a nationally representative sample of parents, we found that 
mean scores on the Vaccination Confidence Scale were consistently associated with 
vaccine refusal and vaccination status across the adolescent platform. The scale's 
4-item short form demonstrated comparable performance. 
A sizable minority of parents in the United States have concerns that lead 
them to refuse or intentionally delay certain vaccines for their children.1 Although 
forgone vaccination has been studied most extensively with regard to vaccines in 
the early childhood schedule,1–5 the problem is also highly relevant to the 
adolescent platform: tetanus, diphtheria, and acellular pertussis (Tdap); 
meningococcal; and human papillomavirus (HPV) vaccines. For example, almost 
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one-third of parents (31%) report having refused or delayed HPV vaccine for an 
age-eligible daughter, and not surprisingly, parental refusal and delay are 
associated with lower HPV vaccination coverage.6 The most common reasons for 
refusing or delaying HPV vaccine are concerns about long-term adverse effects, 
believing the vaccine is not needed, and uncertainty about vaccine effectiveness.6 
National prevalence estimates are not currently available for the refusal and delay 
for Tdap and meningococcal vaccines. However, parents of unvaccinated children 
commonly report that they have not gotten these vaccines for their children as a 
result of lack of information or believing the vaccines are not needed.7 Taken 
together, these findings suggest that parents' vaccination beliefs are important for 
understanding their participation in adolescent immunization programs. 
Efforts to intervene on parents' vaccination beliefs so as to prevent refusal 
and delay of adolescent vaccines are currently hindered by a lack of valid and 
reliable measures for identifying populations most at risk for these behaviors. 
Although researchers, including this study team, have developed scales to assess 
vaccination beliefs with regard to early childhood vaccines or HPV vaccine 
specifically,8,9 the field currently lacks a composite measure capable 
of characterizing adolescent vaccination beliefs more holistically across vaccine 
types. To be most useful, a measure would be validated with regard to adolescents' 
vaccination status as well as with the specific behaviors of parental vaccine refusal 
and delay. The ideal measure would also be very brief so as to minimize participant 
burden and the considerable expense that large surveys typically incur. 
To develop such a tool, we sought to validate the Vaccination Confidence 
Scale, an 8-item, 3-factor measure of vaccination beliefs that our prior research has 
shown to be highly reliable across diverse populations.10 Using a nationally 
representative sample of parents of adolescents, this study aimed to assess 
associations between Vaccination Confidence Scale scores and vaccine refusal, 
vaccine delay, and vaccination status. To increase the utility of the scale, we also 
sought to establish meaningful thresholds for categorizing scale scores as indicating 
low, medium, or high vaccination confidence. Finally, because of the premium 
placed on scale length, we assessed the performance of each of the scale's 3 
factors to identify possible short forms of our measure. By creating a brief, 
validated measure of vaccination beliefs, this study aimed to provide a practical tool 
for understanding and intervening on forgone vaccination among parents of 
adolescents. 
Methods 
Participants and Data Source 
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Data came from the 2010 National Immunization Survey (NIS)-Teen, an 
annual, population-based survey involving 2 phases of data collection. In an initial 
household telephone survey, parents and guardians contacted through random-digit 
dialing provided immunization-related information about a randomly selected 13- to 
17-year-old child in their household. Because most respondents reported being a 
parent of the child in question, we refer to these respondents collectively as 
parents. For children whose parents gave consent, a follow-up, mail-based survey 
of health care providers assessed vaccination status. 
The household response rate for the 2010 NIS-Teen was 58%.11 We drew our 
sample from 11,754 parents who completed the Parental Attitudes Module, a 
special set of questions included in the 2010 NIS-Teen for 2 quarters of data 
collection. We excluded parents who had missing data on parental attitudes or 
vaccination behaviors (n = 2129) or who completed the survey in a language other 
than English (n = 607). Our primary analytic sample consisted of the remaining 
9018 parents. For analyses involving vaccination status, we used a secondary 
analytic sample consisting of the subset of 7173 parents with provider-reported 
vaccination status. 
The National Center for Health Statistics (NCHS) research ethics review 
board approved data collection for the 2010 NIS-Teen. Analysis of deidentified data 
from the survey is exempt from the federal regulations for the protection of human 
research participants. We accessed data from the Parental Attitudes Module through 
the NCHS Research Data Center because these restricted variables are not included 
in the public-use data set. Analysis of restricted data through the NCHS Research 
Data Center was approved by the NCHS Ethics Review Board. The University of 
North Carolina institutional review board determined that this study was exempt 
from further review. 
Measures 
The Parental Attitudes Module assessed parents' beliefs about vaccination 
with survey items conceptualized using the Health Belief Model.12 Items used an 
11-point response scale ranging from 0 (strongly disagree) to 10 (strongly agree). 
In a prior study, we used 8 of 11 available items to develop the Vaccination 
Confidence Scale (Fig. 1). Consisting of 3 factors assessing the benefits of 
vaccination (ie, Benefits), the harms of vaccination (Harms), and trust in health 
care providers (Trust), the scale showed good fit both overall (comparative fit index 
= 0.97; root mean square error of approximation = 0.06) and across subgroups of 
7 demographic factors, including race/ethnicity, poverty status, and child's age.10 
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Figure 1. Factor structure of Vaccination Confidence Scale. 
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Additional items in the Parental Attitudes Module assessed parents' history of 
refusing or delaying vaccines. Parents first indicated whether they had ever 
“refused or decided not to get a vaccination” for their child (ie, any vaccine 
refusal); this item was not specific to adolescent vaccination. For those reporting 
any refusal, separate items assessed whether parents had refused Td/Tdap, a 
meningitis shot, or an HPV shot. Parents next reported whether they had ever 
“delayed or put off getting a vaccination” for their child (ie, any vaccine delay). For 
those reporting any delay, parents indicated which vaccines they had delayed as 
for vaccine refusal. All items on refusal and delay used yes/no response options. 
The 2010 NIS-Teen household survey assessed participant characteristics 
including the child's age, sex, race/ethnicity, and eligibility for the Vaccines for 
Children program (Table 1). Vaccines for Children is a federally funded program 
that provides free vaccines to vulnerable populations, including uninsured and 
Medicaid-eligible youth.13 Respondents indicated their relationship to the child, the 
age and educational attainment of the child's mother, and the annual income and 
geographic location of the household. NCHS analysts classified households as 
urban, suburban, or rural on the basis of metropolitan statistical areas.14 
Table 1. Characteristics of 9018 Participants∗ 
Characteristic N (%) 
Child characteristics  
 Age  
 13 y 1755 (20) 
 14 y 1800 (20) 
 15 y 1843 (20) 
 16 y 1878 (21) 
 17 y 1742 (19) 
 Sex  
 Male 4726 (51) 
 Female 4292 (49) 
 Race/ethnicity  
 Non-Hispanic white 6418 (65) 
 Non-Hispanic black 1068 (16) 
 Hispanic 800 (11) 
 Other 732 (7) 
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Characteristic N (%) 
 Vaccines for children eligibility  
 Yes 1856 (23) 
 No 5303 (55) 
 Not reported 1859 (21) 
Parent characteristics  
 Relationship to child  
 Mother/female guardian 7073 (77) 
 Father/male guardian 1503 (17) 
 Other 442 (6) 
 Parent's age  
 ≤34 y 621 (7) 
 35–44 y 3617 (43) 
 ≥45 y 4780 (50) 
 Parent's education  
 ≤12 y 2409 (35) 
 Some college, no degree 2696 (27) 
 College degree or more 3913 (39) 
Household characteristics  
 Region  
 Northeast 1783 (19) 
 Midwest 1952 (23) 
 South 3360 (38) 
 West 1923 (21) 
 Annual income  
 Below poverty level† 1024 (14) 
 Above poverty level, ≤$75,000 4017 (42) 
 >$75,000 3619 (39) 
 Not reported 358 (4) 
 MSA  
 Urban 3452 (34) 
 Suburban 3448 (48) 
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Characteristic N (%) 
 Rural 2118 (18) 
MSA indicates metropolitan statistical area. 
∗ 
Data are presented as raw frequencies and weighted percentages. 
Percentages may not total 100% as a result of rounding. 
† 
Poverty level based on 2009 US Census poverty threshold. 
The 2010 NIS-Teen provider survey assessed the child's vaccination status. 
Providers used medical records to indicate the dates on which the child received 
vaccine doses, including doses of Td/Tdap, meningococcal, and HPV vaccines. NCHS 
analysts then used vaccination dates to determine whether the child was up to date 
for Td/Tdap, meningococcal vaccine, and HPV vaccine initiation (≥1 dose) and 
completion (3 doses). Because data collection for the 2010 NIS-Teen occurred 
before the addition of HPV vaccine to boys' routine immunization schedule, we 
limited all analyses related to HPV vaccine to girls.15 
Statistical Analyses 
Using the Vaccination Confidence Scale, we reverse-coded negative attitudes 
in the Harms factor and calculated mean scores for each parent by averaging 
responses for all 8 items. The resulting scores had a possible range of 0 to 10, with 
higher scores indicating more positive attitudes about vaccination. To investigate 
the relationship between overall vaccination confidence and vaccination behavior, 
we used separate bivariate logistic regression models to assess the association 
between mean scale scores and vaccine refusal or delay reported for any vaccine, 
or Td/Tdap, meningococcal, or HPV vaccines specifically. We also used bivariate 
logistic regression to assess the association between mean scale scores and 
vaccination status for Td/Tdap, meningococcal vaccine, and HPV vaccine initiation 
and completion. For statistically significant (P < .05) associations, we reran each 
model controlling for demographic factors that we found were associated with 
vaccine refusal or delay: child's race/ethnicity, mother's educational attainment, 
and annual household income. 
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We calculated mean scores for the Benefits, Harms, and Trust factors from 
the scale by averaging the item responses within each factor. We used logistic 
regression to assess the association between mean factor scores and vaccine 
refusal, vaccine delay, and vaccination status in the manner described above. We 
used the findings of these analyses to identify those factors most strongly and 
consistently associated with refusal, delay, and vaccination status; we considered 
these factors as candidates for creating a short form of our scale. 
We next established thresholds for our scale with regard to vaccine refusal. 
The purpose of this analysis was to provide cut points for researchers wishing to 
use our scale to stratify analyses on the basis of risk of refusal. We graphed the 
percentage of parents reporting any vaccine refusal within each 1-point interval in 
mean scores, using all 8 items. We visually inspected the graph to identify changes 
in slope that may indicate natural cut-points. Using the resulting cut points, we 
categorized mean scale and factor scores into low, medium, and high values. We 
used logistic regression to assess associations between these categories and any 
vaccine refusal. We repeated these procedures for the factors previously identified 
as promising candidates for a short form. 
Our analyses used survey weights developed by the NCHS for the primary 
and secondary samples to obtain nationally representative estimates. We report 
raw frequencies and weighted means, percentages, and odds ratios. Conducted in 
SAS 9.3 (SAS Institute, Cary, NC), all statistical tests were 2-tailed with a critical 
alpha of 0.05. 
Results 
Sample Characteristics 
Most parents reported on children who were non-Hispanic white (65%), non-
Hispanic black (16%), or Hispanic (11%) (Table 1). The sample included similar 
numbers of children by age (mean, 15.1 years) and sex (51% male). Most 
respondents were mothers or female guardians (77%). On indicators of 
socioeconomic status, about one-third of children had mothers with a high school 
degree or less education (35%), and over one-tenth (14%) lived in poverty. 
Scale Validation 
Vaccination Confidence 
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Using response scales of 0 to 10, parents reported high overall vaccination 
confidence. The mean score for the full, 8-item scale was 8.19 (standard error 
[SE] = 0.03) after reverse coding for Harms. Factor score means were 8.49 (SE = 
0.03) for Benefits, 3.31 (SE = 0.04) for Harms (without reverse coding), and 9.06 
(SE = 0.03) for Trust. 
Vaccine Refusal 
About one-quarter of parents (24%) reported having refused any vaccine for 
their child, with the prevalence of vaccine-specific refusal being 21% for HPV 
vaccine (girls only), 5% for meningococcal vaccine, and 2% for Tdap (Table 2). For 
the overall scale, vaccination confidence was negatively associated with refusal of 
any vaccine, such that every 1-point increase in mean score corresponded with a 
4% decrease in the odds of refusal (odds ratio [OR], 0.96; 95% confidence interval 
[CI], 0.95–0.96). Vaccination confidence was also negatively associated with 
refusal of Tdap, meningococcal, and HPV vaccines. 
Table 2. Parent-reported Vaccine Refusal: Multivariable Associations With Scale and 
Factor Score Means (n = 9018)∗ 
Characteristic 
Refused 
n (%) 
Scale Factors 
(8 items) 
Benefits (4 
items) 
Harms (2 items) 
Trust (2 
items) 
Mean 
(SE) 
OR (95% 
CI) 
Mean 
(SE) 
OR (95% 
CI) 
Mean 
(SE) 
OR (95% 
CI) 
Mean 
(SE) 
OR 
(95% 
CI) 
Any vaccine          
 Yes 
2186 
(24%) 
7.62 
(0.05) 
0.96 
(0.95, 
0.96) 
7.84 
(0.06) 
0.94 
(0.93, 
0.95) 
3.99 
(0.08) 
1.04 
(1.02, 
1.06) 
8.76 
(0.06) 
— 
 No 
6832 
(76%) 
8.36 
(0.03) 
Reference 
8.70 
(0.03) 
Reference 
3.10 
(0.05) 
Reference 
9.16 
(0.03) 
 
Tdap          
 Yes 174 (2%) 
6.39 
(0.22) 
0.93 
(0.92, 
0.94) 
6.39 
(0.26) 
0.91 
(0.89, 
0.94) 
5.49 
(0.25) 
1.09 
(1.04, 
1.14) 
8.28 
(0.27) 
— 
 No 
8844 
(98%) 
8.21 
(0.03) 
Reference 
8.53 
(0.03) 
Reference 
3.28 
(0.04) 
Reference 
9.08 
(0.03) 
 
Meningococcal          
 Yes 424 (5%) 
6.87 
(0.13) 
0.94 
(0.93, 
0.95) 
6.81 
(0.16) 
0.90 
(0.88, 
0.91) 
4.63 
(0.21) 
— 
8.50 
(0.16) 
— 
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Characteristic 
Refused 
n (%) 
Scale Factors 
(8 items) 
Benefits (4 
items) 
Harms (2 items) 
Trust (2 
items) 
Mean 
(SE) 
OR (95% 
CI) 
Mean 
(SE) 
OR (95% 
CI) 
Mean 
(SE) 
OR (95% 
CI) 
Mean 
(SE) 
OR 
(95% 
CI) 
 No 
8594 
(95%) 
8.24 
(0.03) 
Reference 
8.56 
(0.03) 
Reference 
3.26 
(0.04) 
 9.09 
(0.03) 
 
HPV†          
 Yes 
741 
(21%) 
7.58 
(0.08) 
0.96 
(0.94, 
0.97) 
7.83 
(0.11) 
0.94 
(0.92, 
0.96) 
4.07 
(0.13) 
1.04 
(1.01, 
1.07) 
8.72 
(0.13) 
— 
 No 
2806 
(79%) 
8.34 
(0.05) 
Reference 
8.70 
(0.06) 
Reference 
3.20 
(0.08) 
Reference 
9.17 
(0.04) 
 
SE indicates standard error; OR, odds ratio; CI, confidence interval; Tdap, tetanus, 
diphtheria, and acellular pertussis; and HPV, human papillomavirus. 
∗ 
Shown are raw frequencies and weighted estimates. Models controlled for 
child's race/ethnicity, mother's educational attainment, and annual household 
income. Dashes indicate that findings are not presented because analyses did 
not yield statistically significant associations. 
† 
HPV refusal was assessed only for girls (n = 3547). The model excluded 
parents (n = 745) who had missing data on HPV vaccine refusal. 
Compared to overall confidence scores, scores for the Benefits factor alone 
were somewhat more strongly associated with any vaccine refusal (OR, 0.94; 95% 
CI, 0.93–0.95) as well as with refusal of Tdap, meningococcal, and HPV vaccines. 
Factor scores for Harms were positively associated with refusal of any vaccine, 
Tdap, and HPV vaccine, but not meningococcal vaccine. Factor scores for Trust were 
not associated with any of the 4 refusal measures. 
Vaccine Delay 
Over one-fifth of parents (22%) reported having delayed any vaccine for 
their child, with vaccine-specific delay ranging from 11% for HPV vaccine (girls 
only) to 7% for meningococcal vaccine to 4% for Tdap. Overall confidence scores 
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were weakly associated with delay of any vaccine (OR, 0.99; 95% CI, 0.99–1.00), 
Tdap (OR, 0.97; 95% CI, 0.96–0.98), and meningococcal vaccines (OR, 0.98; 95% 
CI, 0.97–0.98), but not HPV vaccine. Factor scores for Benefits were also 
associated with delay of any vaccine (OR, 0.99; 95% CI, 0.98–1.00) and Tdap (OR, 
0.95; 95% CI, 0.93–0.97). Factor scores for Harms were associated with delay of 
meningococcal vaccine only (OR, 1.06; 95% CI, 1.04–1.09). Factor scores for Trust 
were not associated with any of the 4 delay measures. 
Vaccination Status 
Provider-reported vaccination coverage was highest for Tdap (83%) and 
meningococcal vaccines (66%), with a smaller proportion of girls having initiated 
(52%) or completed (37%) the HPV vaccine series (Table 3). Overall confidence 
scores were positively associated with all 4 measures of vaccination status, with the 
magnitude of the association being highest for HPV vaccine initiation (OR, 1.52; 
95% CI, 1.31–1.68) and lowest for Tdap vaccination (OR, 1.20; 95% CI, 1.11–
1.30). Factor scores for Benefits were also associated with each measure of 
vaccination status, although not as strongly as overall scores. Factor scores for 
Harms were associated with meningococcal vaccination and HPV vaccine initiation. 
Factor scores for Trust were associated with meningococcal vaccination only. 
Table 3. Provider-Reported Vaccination Status: Multivariable Associations With 
Scale and Factor Score Means (n = 7173)∗ 
Characteristic 
Vaccinated 
n (%) 
Scale Factors 
(8 items) 
Benefits (4 
items) 
Harms (2 
items) 
Trust (2 items) 
Mean 
(SE) 
OR 
(95% 
CI) 
Mean 
(SE) 
OR 
(95% 
CI) 
Mean 
(SE) 
OR 
(95% 
CI) 
Mean 
(SE) 
OR 
(95% 
CI) 
Tdap          
 Yes 5969 (83%) 
8.30 
(0.03) 
1.20 
(1.11, 
1.30) 
8.63 
(0.04) 
1.20 
(1.12, 
1.28) 
3.19 
(0.06) 
— 
9.16 
(0.03) 
— 
 No 1204 (17%) 
7.92 
(0.08) 
Reference 
8.13 
(0.10) 
Reference 
3.53 
(0.13) 
 8.97 
(0.06) 
 
Meningococcal          
 Yes 4766 (66%) 
8.41 
(0.04) 
1.31 
(1.22, 
1.39) 
8.72 
(0.04) 
1.17 
(1.09, 
1.26) 
3.05 
(0.07) 
0.96 
(0.92, 
1.00) 
9.24 
(0.04) 
1.09 
(1.01, 
1.18) 
 No 2407 (34%) 
7.89 
(0.05) 
Reference 
8.17 
(0.07) 
Reference 
3.65 
(0.09) 
Reference 
8.89 
(0.05) 
Reference 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be accessed by following the 
link in the citation at the bottom of the page. 
 
[Academic Pediatrics, Vol 16, No. 1 (January-Februray 2016): pg. 42-49. DOI. This article is © [Elsevier] and permission has been granted for this 
version to appear in e-Publications@Marquette. [Elsevier] does not grant permission for this article to be further copied/distributed or hosted 
elsewhere without the express permission from [Elsevier].] 
 
Characteristic 
Vaccinated 
n (%) 
Scale Factors 
(8 items) 
Benefits (4 
items) 
Harms (2 
items) 
Trust (2 items) 
Mean 
(SE) 
OR 
(95% 
CI) 
Mean 
(SE) 
OR 
(95% 
CI) 
Mean 
(SE) 
OR 
(95% 
CI) 
Mean 
(SE) 
OR 
(95% 
CI) 
HPV (≥1 
dose)† 
         
 Yes 1778 (52%) 
8.57 
(0.05) 
1.52 
(1.38, 
1.68) 
8.94 
(0.05) 
1.36 
(1.24, 
1.49) 
2.95 
(0.10) 
0.93 
(0.88, 
0.99) 
9.34 
(0.04) 
— 
 No 1641 (48%) 
7.87 
(0.06) 
Reference 
8.16 
(0.08) 
Reference 
3.79 
(0.10) 
Reference 
8.96 
(0.07) 
 
HPV (3 doses)†          
 Yes 1253 (37%) 
8.61 
(0.06) 
1.46 
(1.31, 
1.64) 
9.01 
(0.06) 
1.41 
(1.28, 
1.55) 
2.93 
(0.12) 
— 
9.38 
(0.05) 
— 
 No 2166 (63%) 
8.01 
(0.05) 
Reference 
8.30 
(0.07) 
Reference 
3.60 
(0.09) 
 9.03 
(0.06) 
 
SE indicates standard error; OR, odds ratio; CI, confidence interval; Tdap, tetanus, 
diphtheria, and acellular pertussis; and HPV, human papillomavirus. 
∗ 
Models controlled for child's race/ethnicity, mother's educational attainment, 
and annual household income. Dashes indicate that findings are not 
presented because analyses did not yield statistically significant associations. 
† 
HPV coverage assessed only for girls (n = 3419). 
Factor Comparison and Thresholds 
Factor Comparison 
On the basis of the validation analyses, we identified the Benefits factor as 
having the strongest factor-specific performance. Compared to scores on the full 
scale, which were associated with 11 of the 12 validation measures of vaccine 
refusal, delay, and vaccination status, scores on the Benefits factor alone were 
associated with 10 measures, and the magnitudes of the associations were 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be accessed by following the 
link in the citation at the bottom of the page. 
 
[Academic Pediatrics, Vol 16, No. 1 (January-Februray 2016): pg. 42-49. DOI. This article is © [Elsevier] and permission has been granted for this 
version to appear in e-Publications@Marquette. [Elsevier] does not grant permission for this article to be further copied/distributed or hosted 
elsewhere without the express permission from [Elsevier].] 
 
comparable in most cases. By comparison, scores on Harms were associated with 6 
validation measures, and scores on Trust were associated with only 1 measure. On 
the basis of these findings, we assessed the Benefits factor in subsequent analyses 
as a short form of our scale. 
Thresholds 
A graph of prevalence of any vaccine refusal by confidence scale scores 
suggested a sharp decrease in prevalence for scores greater than 6 with a smaller 
decrease for scores greater than 8 (Fig. 2). A graph of factors scores for the 4-item 
Benefits factor followed a similar pattern. On the basis of this analysis, we 
categorized overall and individual factor scores as low (≤6), medium (>6 to 8), or 
high (>8). 
 
1. Download high-res image (117KB) 
2. Download full-size image 
Figure 2. Vaccination confidence thresholds for mean scale and factor scores. 
Confidence categories were associated with vaccine refusal in the expected 
order. Parents with medium versus high confidence had about 2 times higher odds 
of reporting any refusal (OR, 2.08; 95% CI, 1.75–2.47) (Table 4). Parents with low 
versus high confidence had over 4 times higher odds of reporting any refusal (OR, 
4.61; 95% CI, 3.51–6.05). Categories for the Benefits factor alone demonstrated 
similar, although slightly weaker, associations such that refusal of any vaccine was 
more common among parents whose scale scores were medium (OR, 1.99; 95% 
CI, 1.65–2.40) or low (OR, 4.07; 95% CI, 3.11–5.34) versus high. 
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Table 4. Parent-Reported Refusal of Any Vaccine: Associations With Scale and 
Factor Categories (n = 9018)∗ 
Mean Score 
Scale (8 items) Benefits Factor (4 items) 
Refused, n 
(%) 
OR (95% CI) 
Refused, n 
(%) 
OR (95% CI) 
Low (≤6) 318 (49) 
4.61 (3.51, 
6.05) 
358 (47) 
4.07 (3.11, 
5.34) 
Medium (>6 to 
8) 
861 (30) 
2.08 (1.75, 
2.47) 
641 (31) 
1.99 (1.65, 
2.40) 
High (>8) 1007 (17) Reference 1187 (18) Reference 
CI indicates confidence interval; and OR, odds ratio. 
∗ 
Data are presented as raw frequencies and weighted estimates. 
Discussion 
Using data from a large, population-based sample of parents, we found that 
mean scores on the Vaccination Confidence Scale were consistently associated with 
vaccine refusal and vaccination status across the adolescent platform. Associations 
were larger in magnitude for vaccination status than vaccine refusal, with 
vaccination confidence showing a particularly strong association with having 
initiated or completed the HPV vaccine series. For example, for every 1-point 
increase in parents' mean scale scores, adolescents had over 50% greater odds of 
having received at least 1 dose of HPV vaccine. Our threshold analyses further 
demonstrated a gradient between confidence and prevalence of vaccine refusal, 
with parents in the low versus high confidence category having over 4 times the 
odds of reporting any refusal. Overall, these findings provide strong support for the 
validity of the Vaccination Confidence Scale as a measure of vaccination beliefs 
associated with vaccine refusal and vaccination status among adolescents. 
We found that mean scale scores were only weakly and inconsistently 
associated with measures of vaccine delay. This finding may reflect a shortcoming 
of our measures of delay, which did not distinguish between intentional delays and 
those that were medically indicated. Alternatively, compared to vaccine refusal, 
vaccine delay may simply be less closely linked with parents' confidence in 
adolescent vaccines; issues such as cost, convenience, or strength of a provider's 
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recommendation may instead be more salient factors.6,16,17 Given that vaccine delay 
is associated with underimmunization and is particularly common with regard to 
HPV vaccination,6 future studies should seek to better understand beliefs associated 
with this behavior. 
In terms of applications, our findings provide support for using the 
Vaccination Confidence Scale to identify populations of parents at risk for refusing 
adolescent vaccines. Such a tool is useful based on research indicating that parents' 
informational needs vary according to whether and how much they are hesitant to 
vaccinate their children.18,19 Using the cut points we have established for our scale, 
researchers can stratify study samples to assess the differential impact of messages 
and other interventions by vaccination confidence. In contrast to these and other 
population-level research applications, the utility of our scale as a clinical screening 
tool for identifying individual parents at risk for vaccine refusal is less clear; before 
the scale could be used in this way, additional research will be needed to assess its 
sensitivity and specificity as well as the feasibility of integrating such a measure 
into clinical care. Future work is also needed to further establish the predictive 
validity of the Vaccination Confidence Scale by prospectively assessing the 
relationship between vaccination confidence and subsequent behavior. 
We were interested to find that the 4-item Benefits factor demonstrated 
comparable performance to the full 8-item scale. Compared to the full scale, mean 
scores for Benefits were slightly more strongly associated with measures of vaccine 
refusal and less strongly associated with vaccination status. In contrast, the Harms 
and Trust factors were inconsistently associated with these measures. These 
findings suggest that perceived benefits are particularly important to understanding 
parents' vaccination behavior.20–22 Indeed, prior studies in health communication 
have found that messages about benefits can increase parents' intentions to 
vaccinate, particularly when those messages emphasize the potential loss of 
benefits.23,24 From a measurement perspective, the successful validation of the 
Benefits factor suggests that it can be used as a short form of the Vaccination 
Confidence Scale, thereby increasing the utility of our measure in the context of 
national surveys or other research activities for which cost and participant burden 
must be strictly managed. 
Strengths of our study include the use of a large, nationally representative 
sample of parents and provider-reported data on vaccination status. To our 
knowledge, this study is the first to validate a measure of vaccination beliefs with 
regard to the behavior of vaccine refusal, which is important as a specific and 
potentially modifiable antecedent to vaccination status. Limitations to this study 
include its cross-sectional design, which prevents us from assessing the 
directionality of the relationship between vaccination confidence and behavior. In 
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addition, our sample consisted of parents of 13- to 17-year-old children, whereas 
practice guidelines recommend 11- to 12-year-old children for the routine 
administration of adolescent vaccines. Although our analyses yielded no evidence to 
suggest that the relationship between vaccination confidence and refusal, delay, or 
vaccination status varied by child's age, our findings will need to be replicated with 
regard to younger children. Future studies should also investigate subgroup 
variation in the association between vaccination confidence and vaccine refusal as 
well as the potential for using the Vaccination Confidence Scale to identify 
populations at risk for refusing other vaccines, including those administered in early 
childhood and HPV vaccine when administered to boys. 
Conclusions 
The Vaccination Confidence Scale shows promise as a tool for identifying 
parents at risk for refusing adolescent vaccines. Mean scores on the 8-item scale 
were associated with vaccine refusal and vaccination status across the adolescent 
platform, and items assessing the perceived benefits of vaccination performed 
especially well. Indeed, our findings suggest that the 4-item Benefits factor can 
serve as a short form for our scale, thereby halving its length, with only small 
trade-offs in performance. As a very brief measure validated with respect to vaccine 
refusal, the Vaccination Confidence Scale can usefully extend our arsenal of 
measurement tools for assessing, and in turn intervening to improve, vaccination 
beliefs. Given that almost one-quarter of parents in our sample reported having 
refused vaccines for their children, our findings underscore the importance of these 
efforts. 
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